ONCOPLEXDX Trademark

Trademark Overview

On Thursday, May 3, 2012, a trademark application was filed for ONCOPLEXDX with the United States Patent and Trademark Office. The USPTO has given the ONCOPLEXDX trademark a serial number of 85615331. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 15, 2023. This trademark is owned by Expression Pathology, Inc.. The ONCOPLEXDX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing diagnostic services in the field of clinical proteomics
oncoplexdx

General Information

Serial Number85615331
Word MarkONCOPLEXDX
Filing DateThursday, May 3, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 15, 2023
Registration Number4347947
Registration DateTuesday, June 4, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 17, 2012

Trademark Statements

Pseudo MarkONCO PLEX DX
Goods and ServicesProviding diagnostic services in the field of clinical proteomics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 15, 2023
Primary Code042
First Use Anywhere DateFriday, June 1, 2012
First Use In Commerce DateTuesday, January 1, 2013

Trademark Owner History

Party NameExpression Pathology, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameExpression Pathology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameExpression Pathology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Friday, December 15, 2023CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, June 4, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, January 8, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, January 8, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, January 8, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, November 19, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, October 1, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 1, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 4, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 4, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, April 30, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, April 29, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, April 22, 2013ASSIGNED TO LIE
Tuesday, April 2, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 19, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 18, 2013STATEMENT OF USE PROCESSING COMPLETE
Friday, March 1, 2013USE AMENDMENT FILED
Monday, March 18, 2013SOU EXTENSION 1 GRANTED
Friday, March 1, 2013SOU EXTENSION 1 FILED
Monday, March 18, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 1, 2013SOU TEAS EXTENSION RECEIVED
Friday, March 1, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, September 11, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 17, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 17, 2012PUBLISHED FOR OPPOSITION
Wednesday, June 27, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 8, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 4, 2012ASSIGNED TO EXAMINER
Thursday, May 10, 2012NOTICE OF PSEUDO MARK MAILED
Wednesday, May 9, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 7, 2012NEW APPLICATION ENTERED

Related Keywords

oncoplexdx clinical proteomics field services diagnostic providing